Literature DB >> 25857266

Pontin, a new mutant p53-binding protein, promotes gain-of-function of mutant p53.

Y Zhao1, C Zhang1, X Yue1, X Li1, J Liu1, H Yu1, V A Belyi1, Q Yang1, Z Feng1, W Hu1.   

Abstract

Tumor-suppressor p53 is frequently mutated in human cancers. Many tumor-associated mutant p53 (mutp53) proteins gain new functions in promoting tumorigenesis, defined as gain-of-function (GOF). The mechanisms for mutp53 GOF are not well understood. Here, we report Pontin, a highly conserved AAA+ ATPase important for various cellular functions, as a new mutp53-binding protein. This Pontin-mutp53 interaction promotes mutp53 GOF in invasion, migration and anchorage-independent growth of tumor cells. The ATPase domain of Pontin is crucial for its promoting effect on mutp53 GOF; blocking the ATPase activity of Pontin by a Pontin-specific ATPase inhibitor or an ATPase-deficient dominant-negative Pontin expression vector greatly diminished mutp53 GOF. Pontin promotes mutp53 GOF through regulation of mutp53 transcriptional activity; knockdown of Pontin abolished the transcriptional regulation of mutp53 toward a group of genes. Furthermore, overexpression of Pontin in tumors is associated with the poor survival in cancer patients, especially those containing mutp53. Our results highlight an important role and mechanism for Pontin, a new mutp53 partner, in promoting mutp53 GOF in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25857266      PMCID: PMC4648328          DOI: 10.1038/cdd.2015.33

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  45 in total

1.  First identification of small-molecule inhibitors of Pontin by combining virtual screening and enzymatic assay.

Authors:  Judith Elkaim; Michel Castroviejo; Driss Bennani; Said Taouji; Nathalie Allain; Michel Laguerre; Jean Rosenbaum; Jean Dessolin; Patrick Lestienne
Journal:  Biochem J       Date:  2012-04-15       Impact factor: 3.857

2.  An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients.

Authors:  Balazs Györffy; Andras Lanczky; Aron C Eklund; Carsten Denkert; Jan Budczies; Qiyuan Li; Zoltan Szallasi
Journal:  Breast Cancer Res Treat       Date:  2009-12-18       Impact factor: 4.872

3.  Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway.

Authors:  William A Freed-Pastor; Hideaki Mizuno; Xi Zhao; Anita Langerød; Sung-Hwan Moon; Ruth Rodriguez-Barrueco; Anthony Barsotti; Agustin Chicas; Wencheng Li; Alla Polotskaia; Mina J Bissell; Timothy F Osborne; Bin Tian; Scott W Lowe; Jose M Silva; Anne-Lise Børresen-Dale; Arnold J Levine; Jill Bargonetti; Carol Prives
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

4.  A member of the ETS family, EHF, and the ATPase RUVBL1 inhibit p53-mediated apoptosis.

Authors:  Kenzui Taniue; Takeaki Oda; Tomoatsu Hayashi; Masumi Okuno; Tetsu Akiyama
Journal:  EMBO Rep       Date:  2011-07-01       Impact factor: 8.807

Review 5.  The regulation of energy metabolism and the IGF-1/mTOR pathways by the p53 protein.

Authors:  Zhaohui Feng; Arnold J Levine
Journal:  Trends Cell Biol       Date:  2010-07       Impact factor: 20.808

6.  A Pin1/mutant p53 axis promotes aggressiveness in breast cancer.

Authors:  Javier E Girardini; Marco Napoli; Silvano Piazza; Alessandra Rustighi; Carolina Marotta; Enrico Radaelli; Valeria Capaci; Lee Jordan; Phil Quinlan; Alastair Thompson; Miguel Mano; Antonio Rosato; Tim Crook; Eugenio Scanziani; Anthony R Means; Guillermina Lozano; Claudio Schneider; Giannino Del Sal
Journal:  Cancer Cell       Date:  2011-07-12       Impact factor: 31.743

7.  Negative regulation of tumor suppressor p53 by microRNA miR-504.

Authors:  Wenwei Hu; Chang S Chan; Rui Wu; Cen Zhang; Yvonne Sun; Jun S Song; Laura H Tang; Arnold J Levine; Zhaohui Feng
Journal:  Mol Cell       Date:  2010-06-11       Impact factor: 17.970

8.  Annexin-1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-κB: implication in breast cancer metastasis.

Authors:  P Bist; S C Leow; Q H Phua; S Shu; Q Zhuang; W T Loh; T H Nguyen; J B Zhou; S C Hooi; L H K Lim
Journal:  Oncogene       Date:  2011-03-07       Impact factor: 9.867

Review 9.  The first 30 years of p53: growing ever more complex.

Authors:  Arnold J Levine; Moshe Oren
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

10.  ITPR1 protects renal cancer cells against natural killer cells by inducing autophagy.

Authors:  Yosra Messai; Muhammad Zaeem Noman; Meriem Hasmim; Bassam Janji; Andrés Tittarelli; Marie Boutet; Véronique Baud; Elodie Viry; Katy Billot; Arash Nanbakhsh; Thouraya Ben Safta; Catherine Richon; Sophie Ferlicot; Emmanuel Donnadieu; Sophie Couve; Betty Gardie; Florence Orlanducci; Laurence Albiges; Jerome Thiery; Daniel Olive; Bernard Escudier; Salem Chouaib
Journal:  Cancer Res       Date:  2014-10-08       Impact factor: 12.701

View more
  23 in total

1.  Pontin, a novel interactor of mutant p53 that promotes mutant p53 gain of function.

Authors:  Yuhan Zhao; Xuetian Yue; Wenwei Hu
Journal:  Mol Cell Oncol       Date:  2015-07-29

Review 2.  Mutant p53 in Cancer: Accumulation, Gain-of-Function, and Therapy.

Authors:  Xuetian Yue; Yuhan Zhao; Yang Xu; Min Zheng; Zhaohui Feng; Wenwei Hu
Journal:  J Mol Biol       Date:  2017-04-06       Impact factor: 5.469

3.  The transcriptional coactivator RUVBL2 regulates Pol II clustering with diverse transcription factors.

Authors:  Hui Wang; Boyuan Li; Linyu Zuo; Bo Wang; Yan Yan; Kai Tian; Rong Zhou; Chenlu Wang; Xizi Chen; Yongpeng Jiang; Haonan Zheng; Fangfei Qin; Bin Zhang; Yang Yu; Chao-Pei Liu; Yanhui Xu; Juntao Gao; Zhi Qi; Wulan Deng; Xiong Ji
Journal:  Nat Commun       Date:  2022-09-28       Impact factor: 17.694

Review 4.  How do oncoprotein mutations rewire protein-protein interaction networks?

Authors:  Emily H Bowler; Zhenghe Wang; Rob M Ewing
Journal:  Expert Rev Proteomics       Date:  2015-09-01       Impact factor: 3.940

Review 5.  Non-canonical roles of canonical telomere binding proteins in cancers.

Authors:  Semih Can Akincilar; Claire Hian Tzer Chan; Qin Feng Ng; Kerem Fidan; Vinay Tergaonkar
Journal:  Cell Mol Life Sci       Date:  2021-02-18       Impact factor: 9.261

6.  Pontin Functions as A Transcriptional Co-activator for Retinoic Acid-induced HOX Gene Expression.

Authors:  Dan Tang; Zhao Zhang; Emily Zboril; Michael D Wetzel; Xinping Xu; Wei Zhang; Lizhen Chen; Zhijie Liu
Journal:  J Mol Biol       Date:  2021-03-11       Impact factor: 6.151

7.  BAG2 promotes tumorigenesis through enhancing mutant p53 protein levels and function.

Authors:  Xuetian Yue; Yuhan Zhao; Juan Liu; Cen Zhang; Haiyang Yu; Jiabei Wang; Tongsen Zheng; Lianxin Liu; Jun Li; Zhaohui Feng; Wenwei Hu
Journal:  Elife       Date:  2015-08-13       Impact factor: 8.140

8.  Glutaminase 2 is a novel negative regulator of small GTPase Rac1 and mediates p53 function in suppressing metastasis.

Authors:  Cen Zhang; Juan Liu; Yuhan Zhao; Xuetian Yue; Yu Zhu; Xiaolong Wang; Hao Wu; Felix Blanco; Shaohua Li; Gyan Bhanot; Bruce G Haffty; Wenwei Hu; Zhaohui Feng
Journal:  Elife       Date:  2016-01-11       Impact factor: 8.140

9.  A novel mutant p53 binding partner BAG5 stabilizes mutant p53 and promotes mutant p53 GOFs in tumorigenesis.

Authors:  Xuetian Yue; Yuhan Zhao; Grace Huang; Jun Li; Junlan Zhu; Zhaohui Feng; Wenwei Hu
Journal:  Cell Discov       Date:  2016-11-01       Impact factor: 10.849

10.  Parkin targets HIF-1α for ubiquitination and degradation to inhibit breast tumor progression.

Authors:  Juan Liu; Cen Zhang; Yuhan Zhao; Xuetian Yue; Hao Wu; Shan Huang; James Chen; Kyle Tomsky; Haiyang Xie; Christen A Khella; Michael L Gatza; Dajing Xia; Jimin Gao; Eileen White; Bruce G Haffty; Wenwei Hu; Zhaohui Feng
Journal:  Nat Commun       Date:  2017-11-28       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.